Invion Ltd banner

Intrinsic Value

The intrinsic value of Invion Ltd (IVIXF) under the Base Case is 0.0667 USD per share. Compared with the current market price of 0.0369 USD, the stock appears Undervalued by 45% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

IVIXF Intrinsic Value
$0.0667
Undervaluation 45%
Intrinsic Value
Price $0.0369

We don’t have enough historical valuation data to make this comparison.

Monitor IVIXF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.05
Get notified when the price drops into your buy zone
Intrinsic Value $0.07
Margin of Safety 20% $0.05
Current Price $0.04
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to IVIXF

Fundamental Analysis

What Invion Does

Pharmaceuticals Health Care

Invion Ltd. is a clinical-stage life sciences company, which engages in the research and development of treatment for cancers, atherosclerosis, and infectious diseases. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-02-15. The firm is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases.

Headquarters
Australia AU
IPO date
Feb 15, 2010
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Invion Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

IVX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IVIXF stock?

The intrinsic value for Invion Ltd (IVIXF) under the Base Case is 0.0667 USD.

Is IVIXF stock undervalued or overvalued?

Compared with the current market price of 0.0369 USD, the stock appears Undervalued by 45% .

Back to Top